Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Markus Reischl is active.

Publication


Featured researches published by Markus Reischl.


Reproductive Toxicology | 2009

Zebrafish embryos as models for embryotoxic and teratological effects of chemicals

Lixin Yang; Nga Yu Ho; Rüdiger Alshut; Jessica Legradi; Carsten Weiss; Markus Reischl; Ralf Mikut; Urban Liebel; Ferenc Müller; Uwe Strähle

The experimental virtues of the zebrafish embryo such as small size, development outside of the mother, cheap maintenance of the adult made the zebrafish an excellent model for phenotypic genetic and more recently also chemical screens. The availability of a genome sequence and several thousand mutants and transgenic lines together with gene arrays and a broad spectrum of techniques to manipulate gene functions add further to the experimental strength of this model. Pioneering studies suggest that chemicals can have in many cases very similar toxicological and teratological effects in zebrafish embryos and humans. In certain areas such as cardiotoxicity, the zebrafish appears to outplay the traditional rodent models of toxicity testing. Several pilot projects used zebrafish embryos to identify new chemical entities with specific biological functions. In combination with the establishment of transgenic sensor lines and the further development of existing and new automated imaging systems, the zebrafish embryos could therefore be used as cost-effective and ethically acceptable animal models for drug screening as well as toxicity testing.


Modern Pathology | 2011

SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer

Theresia Wilbertz; Patrick L. Wagner; Karen Petersen; Ann-Cathrin Stiedl; Veit Scheble; Sebastian Maier; Markus Reischl; Ralf Mikut; Nasser K. Altorki; Holger Moch; Falko Fend; Annette Staebler; Adam J. Bass; Matthew Meyerson; Mark A. Rubin; Alex Soltermann; Claudia Lengerke; Sven Perner

The transcription factor SOX2 (3q26.3–q27) is a key regulator of foregut development and an embryonic stem cell factor cooperating during induction of pluripotency in terminally differentiated somatic cells. Recently, we found SOX2 to be amplified in a subset of squamous cell lung and esophageal cancers. The aim of this study was to explore the prognostic role of SOX2 in a large series of squamous cell carcinomas and adenocarcinomas of the lung. A total of 891 samples from two independent population-based cohorts were assessed by fluorescence in situ hybridization and immunohistochemistry. Furthermore, we assessed for associations between SOX2 amplification/upregulation and clinicopathological features. Similar results were found in the two cohorts. Within squamous cell carcinoma cases, 8% high-level as well as 68 and 65% low-level SOX2 amplifications occurred in the two cohorts, respectively. In adenocarcinomas, no high-level amplification was found and low-level amplification occurred in 6% of the two cohorts. Within squamous cell carcinomas of one cohort, SOX2 amplification was associated with lower tumor grade, while higher levels of SOX2 expression were related to younger age, smaller tumor size, and lower probability of angiolymphatic invasion and metastasis. High SOX2 expression levels proved to be a marker for prolonged overall survival among patients with squamous cell carcinomas. In conclusion, SOX2 amplification and upregulation are frequent events in squamous cell carcinomas of the lung and are associated with indicators of favorable prognosis.


Cell Reports | 2014

Autophagy impairment in muscle induces neuromuscular junction degeneration and precocious aging.

Silvia Carnio; Francesca LoVerso; Martin A. Baraibar; Emanuela Longa; Muzamil Majid Khan; Manuela Maffei; Markus Reischl; Monica Canepari; Stefan Loefler; Helmut Kern; Bert Blaauw; Bertrand Friguet; Roberto Bottinelli; Rüdiger Rudolf; Marco Sandri

Summary The cellular basis of age-related tissue deterioration remains largely obscure. The ability to activate compensatory mechanisms in response to environmental stress is an important factor for survival and maintenance of cellular functions. Autophagy is activated both under short and prolonged stress and is required to clear the cell of dysfunctional organelles and altered proteins. We report that specific autophagy inhibition in muscle has a major impact on neuromuscular synaptic function and, consequently, on muscle strength, ultimately affecting the lifespan of animals. Inhibition of autophagy also exacerbates aging phenotypes in muscle, such as mitochondrial dysfunction, oxidative stress, and profound weakness. Mitochondrial dysfunction and oxidative stress directly affect acto-myosin interaction and force generation but show a limited effect on stability of neuromuscular synapses. These results demonstrate that age-related deterioration of synaptic structure and function is exacerbated by defective autophagy.


Modern Pathology | 2010

ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor

Veit Scheble; Martin Braun; Rameen Beroukhim; Craig H. Mermel; Christian Ruiz; Theresia Wilbertz; Ann-Cathrin Stiedl; Karen Petersen; Markus Reischl; Rainer Kuefer; David Schilling; Falko Fend; Glen Kristiansen; Matthew Meyerson; Mark A. Rubin; Lukas Bubendorf; Sven Perner

Identification of specific somatic gene alterations is crucial for the insight into the development, progression, and clinical behavior of individual cancer types. The recently discovered recurrent ERG rearrangement in prostate cancer might represent a prostate cancer-specific alteration that has not been systematically assessed in tumors other than prostate cancer. Aim of this study was to assess, whether the ERG rearrangement and the distinct deletion site between TMPRSS2 and ERG, both predominantly resulting in a TMPRSS2–ERG fusion, occur in tumors other than prostate cancer. We assessed 54 different tumor types (2942 samples in total) for their ERG rearrangement status by fluorescence in situ hybridization (FISH). To calibrate, we analyzed 285 prostate cancer samples for the ERG rearrangement frequency. Additionally, we interrogated a high-resolution single nucleotide polymorphism (SNP) data set across 3131 cancer specimens (26 tumor types) for copy number alterations. None of the 54 different tumor types assessed by FISH harbored an ERG rearrangement, whereas the prostate cancer samples revealed an ERG rearrangement in 49.5% of cases. Furthermore, within the 26 tumor types assessed for copy number alterations by SNP, the distinct deletion site between TMPRSS2 and ERG (21q22.2–3) was detectable exclusively in prostate cancer. Although Ewings sarcoma and AML have known rearrangements rarely involving ERG, we hypothesize that the ERG rearrangement as well as the distinct deletion site on 21q22.2–3 between TMPRSS2 and ERG are prostate-cancer-specific genomic alterations. These observations provide further insight into the oncogenesis of prostate cancer and might be critical for the development of ERG rearrangement assessment as a clinical tool.


Nature Methods | 2009

Automated high-throughput mapping of promoter-enhancer interactions in zebrafish embryos.

Jochen Gehrig; Markus Reischl; Éva Kalmár; Marco Ferg; Yavor Hadzhiev; Andreas Zaucker; Chengyi Song; Simone Schindler; Urban Liebel; Ferenc Müller

Zebrafish embryos offer a unique combination of high-throughput capabilities and the complexity of the vertebrate animal for a variety of phenotypic screening applications. However, there is a need for automation of imaging technologies to exploit the potential of the transparent embryo. Here we report a high-throughput pipeline for registering domain-specific reporter expression in zebrafish embryos with the aim of mapping the interactions between cis-regulatory modules and core promoters. Automated microscopy coupled with custom-built embryo detection and segmentation software allowed the spatial registration of reporter activity for 202 enhancer-promoter combinations, based on images of thousands of embryos. The diversity of promoter-enhancer interaction specificities underscores the importance of the core promoter sequence in cis-regulatory interactions and provides a promoter resource for transgenic reporter studies. The technology described here is also suitable for the spatial analysis of fluorescence readouts in genetic, pharmaceutical or toxicological screens.


Wiley Interdisciplinary Reviews-Data Mining and Knowledge Discovery | 2011

Data mining tools

Ralf Mikut; Markus Reischl

The development and application of data mining algorithms requires the use of powerful software tools. As the number of available tools continues to grow, the choice of the most suitable tool becomes increasingly difficult. This paper attempts to support the decision‐making process by discussing the historical development and presenting a range of existing state‐of‐the‐art data mining and related tools. Furthermore, we propose criteria for the tool categorization based on different user groups, data structures, data mining tasks and methods, visualization and interaction styles, import and export options for data and models, platforms, and license policies. These criteria are then used to classify data mining tools into nine different types. The typical characteristics of these types are explained and a selection of the most important tools is categorized. This paper is organized as follows: the first section Historical Development and State‐of‐the‐Art highlights the historical development of data mining software until present; the criteria to compare data mining software are explained in the second section Criteria for Comparing Data Mining Software. The last section Categorization of Data Mining Software into Different Types proposes a categorization of data mining software and introduces typical software tools for the different types.


Human Pathology | 2011

SOX2 amplification is a common event in squamous cell carcinomas of different organ sites

Sebastian Maier; Theresia Wilbertz; Martin Braun; Veit Scheble; Markus Reischl; Ralf Mikut; Roopika Menon; Pavel Nikolov; Karen Petersen; Christine Beschorner; Holger Moch; Christoph Kakies; Chris Protzel; Jürgen Bauer; Alex Soltermann; Falko Fend; Annette Staebler; Claudia Lengerke; Sven Perner

Acquired chromosomal aberrations, including gene copy number alterations, are involved in the development and progression of human malignancies. SOX2, a transcription factor-coding gene located at 3q26.33, is known to be recurrently and specifically amplified in squamous cell carcinomas of the lung, the esophagus, and the oral cavity. In these organs, the SOX2 protein plays an important role in tumorigenesis and tumor survival. The aim of this study was to determine whether SOX2 amplification is also found in squamous cell carcinomas in other organs commonly affected by this tumor entity. In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung. Applying fluorescence in situ hybridization, we assessed squamous cell carcinomas of the cervix uteri (n = 47), the skin (n = 57), and the penis (n = 53) for SOX2 copy number alterations and detected amplifications in 28%, 28%, and 32% of tumors, respectively. Furthermore, we performed immunohistochemical SOX2 staining and found that SOX2 amplification is significantly associated with overexpression of the corresponding protein in squamous cell carcinomas (P < .001). Of the lung cancer entities with neuroendocrine differentiation, only small cell cancers and large cell cancers exhibited SOX2 or TTF1 amplifications at significant frequencies, indicating that at least a subset of these might be dedifferentiated forms of squamous cell carcinomas or adenocarcinomas of the lung. We conclude that SOX2 amplification and consequent SOX2 protein overexpression may represent important mechanisms of tumor initiation and progression in a considerable subset of squamous cell carcinomas.


Histopathology | 2010

ERG rearrangement in small cell prostatic and lung cancer

Veit Scheble; Martin Braun; Theresia Wilbertz; Ann-Cathrin Stiedl; Karen Petersen; David Schilling; Markus Reischl; Gerhard Seitz; Falko Fend; Glen Kristiansen; Sven Perner

Scheble V J, Braun M, Wilbertz T, Stiedl A‐C, Petersen K, Schilling D, Reischl M, Seitz G, Fend F, Kristiansen G & Perner S
(2010) Histopathology 56, 937–943
ERG rearrangement in small cell prostatic and lung cancer


Robotica | 2005

A hydraulically driven multifunctional prosthetic hand

Stefan Schulz; Christian Pylatiuk; Markus Reischl; Jan Martin; Ralf Mikut; Georg Bretthauer

In this paper a new prosthetic hand is presented that closely approximates the grasping abilities of a human hand. A large variety of different objects can be grasped reliably and the movements of the hand appear to natural. This five-finger hand has 15 degrees of freedom driven by small sized flexible fluidic actuators. The drives are within the fingers allowing a very compact and lightweight hand. Also, a concept for the control of different grasp types is presented. The characteristics of the new hand are illustrated.


Proceedings of the National Academy of Sciences of the United States of America | 2010

Myosin Va cooperates with PKA RIα to mediate maintenance of the endplate in vivo

Ira V. Röder; Kyeong-Rock Choi; Markus Reischl; Yvonne Petersen; Markus E. Diefenbacher; Manuela Zaccolo; Tullio Pozzan; Rüdiger Rudolf

Myosin V motor proteins facilitate recycling of synaptic receptors, including AMPA and acetylcholine receptors, in central and peripheral synapses, respectively. To shed light on the regulation of receptor recycling, we employed in vivo imaging of mouse neuromuscular synapses. We found that myosin Va cooperates with PKA on the postsynapse to maintain size and integrity of the synapse; this cooperation also regulated the lifetime of acetylcholine receptors. Myosin Va and PKA colocalized in subsynaptic enrichments. These accumulations were crucial for synaptic integrity and proper cAMP signaling, and were dependent on AKAP function, myosin Va, and an intact actin cytoskeleton. The neuropeptide and cAMP agonist, calcitonin-gene related peptide, rescued fragmentation of synapses upon denervation. We hypothesize that neuronal ligands trigger local activation of PKA, which in turn controls synaptic integrity and turnover of receptors. To this end, myosin Va mediates correct positioning of PKA in a postsynaptic microdomain, presumably by tethering PKA to the actin cytoskeleton.

Collaboration


Dive into the Markus Reischl's collaboration.

Top Co-Authors

Avatar

Ralf Mikut

Karlsruhe Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Christian Pylatiuk

Karlsruhe Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Uwe Strähle

Karlsruhe Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Urban Liebel

Karlsruhe Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rüdiger Alshut

Karlsruhe Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Johannes Stegmaier

Karlsruhe Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Rüdiger Rudolf

Karlsruhe Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Stefan Schulz

Hamburg University of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge